Delivery Order SPE2DB22D3011-SPE2DB26FP7HN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger pharmaceutical supply contract with DLA. The award specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.08 to AmerisourceBergen Drug Corp for ACT-O-VIALS on October 22, 2025, with completion scheduled for October 23, 2025. This contract is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $6,860.20 to AmerisourceBergen Drug Corp for Act-O-Vials pharmaceutical products on September 17, 2025, with completion expected by September 18, 2025. This firm fixed-price contract, issued without a set-aside designation, represents a competitively awarded order for medical supplies to support federal healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $13,720.40 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on October 23, 2025, with an ultimate completion date of October 24, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $173,475.80 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for Act-O-Vials on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed price delivery order represents a non-competitive award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $14,404.40 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $21,606.60 to AmerisourceBergen Drug Corp for ACT-O-VIALS on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order represents a non-competed award under the company's existing contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ACT-O-VIALS are specialized medical supply vials that support pharmaceutical...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7HNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,743.60 to AmerisourceBergen Drug Corp for Act-O-Vials on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-competitive, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The Act-O-Vials delivery represents part of the company's ongoing role as a pharmaceutical prime vendor serving the Defense Health Agency and other government healthcare systems through this flexible global contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 10/30/25 |